{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T18:01:22Z","timestamp":1772128882144,"version":"3.50.1"},"reference-count":154,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T00:00:00Z","timestamp":1611878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Central serous chorioretinopathy (CSC) is a controversial disease both in terms of clinical classification and choice of therapeutic strategy. Choroidal layers, retinal pigment epithelium (RPE), photoreceptors, and retina are involved to varying degrees. Beyond well-known symptoms raising the clinical suspect of CSC and slit-lamp fundus examination, multimodal imaging plays a key role in assessing the extent of chorioretinal structural involvement. Subretinal fluid (SRF) originating from the choroid leaks through one or multiple RPE defects and spreads into the subretinal space. Spontaneous fluid reabsorption is quite common, but in some eyes, resolution can be obtained only after treatment. Multiple therapeutic strategies are available, and extensive research identified the most effective procedures. Imaging has carved a significant role in guiding the choice of the most appropriate strategy for each single CSC eye. Multiple biomarkers have been identified, and all of them represent a diagnostic and prognostic reference point. This review aims to provide an updated and comprehensive analysis of the current scientific knowledge about the role of imaging in planning the treatment in eyes affected by CSC.<\/jats:p>","DOI":"10.3390\/ph14020105","type":"journal-article","created":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T09:25:22Z","timestamp":1611912322000},"page":"105","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The Role of Imaging in Planning Treatment for Central Serous Chorioretinopathy"],"prefix":"10.3390","volume":"14","author":[{"given":"Stefano","family":"Da Pozzo","sequence":"first","affiliation":[{"name":"TS Retina, 34170 Trieste, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4562-539X","authenticated-orcid":false,"given":"Pierluigi","family":"Iacono","sequence":"additional","affiliation":[{"name":"IRCCS\u2014Fondazione Bietti, 00198 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4715-8414","authenticated-orcid":false,"given":"Alessandro","family":"Arrigo","sequence":"additional","affiliation":[{"name":"Ophthalmology Department, San Raffaele University Hospital, 20132 Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0385-7961","authenticated-orcid":false,"given":"Maurizio","family":"Battaglia Parodi","sequence":"additional","affiliation":[{"name":"TS Retina, 34170 Trieste, Italy"},{"name":"Ophthalmology Department, San Raffaele University Hospital, 20132 Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,1,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1001\/archopht.1974.03900060257001","article-title":"Experience with Nontreatment of Central Serous Choroidopathy","volume":"91","author":"Klein","year":"1974","journal-title":"Arch. Ophthalmol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ajo.2009.11.017","article-title":"Central Serous Chorioretinopathy: A Personal Perspective","volume":"149","author":"Yannuzzi","year":"2010","journal-title":"Am. J. Ophthalmol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2147\/OPTH.S115685","article-title":"Chronic central serous chorioretinopathy: Long-term follow-up and vision-related quality of life","volume":"11","author":"Breukink","year":"2016","journal-title":"Clin. Ophthalmol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ophtha.2018.12.048","article-title":"Long-term Visual Outcomes and Causes of Vision Loss in Chronic Central Serous Chorioretinopathy","volume":"126","author":"Mrejen","year":"2019","journal-title":"Ophthalmology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.survophthal.2012.07.004","article-title":"Central Serous Chorioretinopathy: Update on Pathophysiology and Treatment","volume":"58","author":"Nicholson","year":"2013","journal-title":"Surv. Ophthalmol."},{"key":"ref_6","unstructured":"Gass, J.D.M. (1997). Stereoscopic Atlas of Macular Diseases: Diagnosis and Treatment, Mosby-Yearbook. [4th ed.]."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0039-6257(00)00123-5","article-title":"Fluorescence Properties and Metabolic Features of Indocyanine Green (ICG) as Related to Angiography","volume":"45","author":"Desmettre","year":"2000","journal-title":"Surv. Ophthalmol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/S0161-6420(89)32826-0","article-title":"Indocyanine Green Videoangiography of Choroidal Neovascularization","volume":"96","author":"Destro","year":"1989","journal-title":"Ophthalmology"},{"key":"ref_9","first-page":"57","article-title":"Clinical application of indocyanine angiography to choroidal ne-ovascularization","volume":"33","author":"Hayashi","year":"1989","journal-title":"Jpn. J. Ophthalmol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000310315","article-title":"Fluorescein-angiographic patterns in patients with central serous chori-oretinopathy at the initial visit","volume":"205","author":"Yamada","year":"1992","journal-title":"Ophthalmologica"},{"key":"ref_11","first-page":"342","article-title":"Angiographic characteristics of central serous chorioretinopathy in an Egyptian population","volume":"6","author":"Shahin","year":"2013","journal-title":"Int. J. Ophthalmol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00417-009-1212-5","article-title":"Smokestack leak in central serous chorioretinopathy","volume":"248","author":"Bujarborua","year":"2009","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1016\/S0161-6420(84)34117-3","article-title":"Peripheral retinal detachments and retinal pigment epithe-lial atrophic tracts secondary to central serous pigment epitheliopathy","volume":"91","author":"Yannuzzi","year":"1984","journal-title":"Ophthalmology"},{"key":"ref_14","first-page":"529","article-title":"Central serous chorioretinopathy. Clinical, fluorescein angiography and demographic aspects","volume":"95","author":"Lang","year":"1998","journal-title":"Der Ophthalmol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF00225936","article-title":"Indocyanine green angiography of central serous chorioretinopathy","volume":"9","author":"Hayashi","year":"1986","journal-title":"Int. Ophthalmol."},{"key":"ref_16","first-page":"359","article-title":"Polypoidal Choroidal Vasculopathy: An Update on Therapeutic Approaches","volume":"8","author":"Wong","year":"2013","journal-title":"J. Ophthalmic Vis. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1097\/IAE.0000000000000482","article-title":"Improved specificity of polypoidal choroidal vasculopathy diagnosis using a modified everest criteria","volume":"35","author":"Cheung","year":"2015","journal-title":"Retina"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/IAE.0b013e3182852446","article-title":"Polypoidal choroidal vasculopathy: Evidence-based guide-lines for clinical diagnosis and treatment","volume":"33","author":"Koh","year":"2013","journal-title":"Retina"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1136\/bjophthalmol-2014-305674","article-title":"EVEREST study report 2: Imaging and grading protocol, and baseline characteristics of a randomised controlled trial of polypoidal choroidal vasculopa-thy","volume":"99","author":"Tan","year":"2015","journal-title":"Br. J. Ophthalmol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/eye.2009.323","article-title":"Polypoidal choroidal vasculopathy: An angiographic discussion","volume":"24","author":"Lim","year":"2010","journal-title":"Eye"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1007\/s00417-016-3333-y","article-title":"EVEREST study report 3: Diagnostic chal-lenges of polypoidal choroidal vasculopathy: Lessons learnt from screening failures in the EVEREST study","volume":"254","author":"Tan","year":"2016","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1023\/A:1005880129005","article-title":"Indocyanine green angiography in central serous chorioretinopathy","volume":"21","author":"Menchini","year":"1997","journal-title":"Int. Ophthalmol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1023\/A:1006038621426","article-title":"Long-term follow-up of severe central serous chorioretinopathy using indocyanine green angiography","volume":"21","author":"Shiraki","year":"1997","journal-title":"Int. Ophthalmol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1097\/IAE.0b013e3181c72068","article-title":"Punctate hyperfluorescent spots as-sociated with central serous chorioretinopathy as seen on indocyanine green angiography","volume":"30","author":"Tsujikawa","year":"2010","journal-title":"Retina"},{"key":"ref_25","first-page":"878","article-title":"Analysis of fundus fluorescein angiography, indocyanine green angiography and choroidal thickness in central serous chorioretinopathy","volume":"48","author":"Li","year":"2012","journal-title":"Zhonghua Yan Ke Za Zhi Chin. J. Ophthalmol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.ajo.2014.08.010","article-title":"Punctate hyperfluorescence spot as a common choroidopathy of central se-rous chorioretinopathy and polypoidal choroidal vasculopathy","volume":"158","author":"Park","year":"2014","journal-title":"Am. J. Ophthalmol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ajo.2014.04.021","article-title":"Ultra-Widefield Imaging with Autofluorescence and Indocyanine Green Angiography in Central Serous Chorioretinopathy","volume":"158","author":"Pang","year":"2014","journal-title":"Am. J. Ophthalmol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ajo.2016.03.040","article-title":"Densitometry of Choroidal Vessels in Eyes with and without Central Serous Chorioretinopathy by Wide-Field Indocyanine Green Angiography","volume":"166","author":"Hirahara","year":"2016","journal-title":"Am. J. Ophthalmol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0002-9394(83)90265-9","article-title":"Direct, Indirect, and Sham Laser Photocoagulation in the Management of Central Serous Chorioretinopathy","volume":"95","author":"Robertson","year":"1983","journal-title":"Am. J. Ophthalmol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/S0161-6420(86)33652-2","article-title":"Argon Laser Photocoagulation Treatment in Central Serous Chorioretinopathy","volume":"93","author":"Robertson","year":"1986","journal-title":"Ophthalmology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1136\/bjo.72.11.829","article-title":"Long-term follow-up of a prospective trial of argon laser photocoagula-tion in the treatment of central serous retinopathy","volume":"72","author":"Ficker","year":"1988","journal-title":"Br. J. Ophthalmol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1016\/j.ophtha.2008.08.026","article-title":"Subthreshold Diode Micropulse Photocoagulation for the Treatment of Chronic Central Serous Chorioretinopathy with Juxtafoveal Leakage","volume":"115","author":"Chen","year":"2008","journal-title":"Ophthalmology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1097\/IAE.0000000000001005","article-title":"Low-intensity\/high-density subthreshold diode micropulse laser for central serous chorioretinopa-thy","volume":"36","author":"Luttrull","year":"2016","journal-title":"Retina"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/IAE.0000000000000285","article-title":"Low-intensity\/high-density subthreshold micropulse diode laser for chronic central serous chorioretinopathy","volume":"35","author":"Malik","year":"2015","journal-title":"Retina"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.ophtha.2018.04.021","article-title":"Half-dose photodynamic therapy ver-sus high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy: The Place trial","volume":"125","author":"Fauser","year":"2018","journal-title":"Ophthalmology"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.2147\/OPTH.S67025","article-title":"Navigated focal laser photocoagulation for central serous chorioretinopathy","volume":"8","author":"Chhablani","year":"2014","journal-title":"Clin. Ophthalmol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1007\/s00417-018-4031-8","article-title":"Navigated laser photocoagulation in patients with non-resolving and chronic central serous chorioretinopathy","volume":"256","author":"Tatsios","year":"2018","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajo.2019.03.025","article-title":"Focal and diffuse chronic central serous chorioretinopathy treated with half-dose photodynamic therapy or subthreshold micropulse laser","volume":"205","author":"Scholz","year":"2019","journal-title":"Am. J. Ophthalmol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.2147\/OPTH.S151933","article-title":"Long-term outcomes in half-dose verteporfin photodynamic therapy for chronic central serous retinopathy","volume":"11","author":"Dhirani","year":"2017","journal-title":"Clin. Ophthalmol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Haga, F., Maruko, R., Sato, C., Kataoka, K., Ito, Y., and Terasaki, H. (2017). Long-term prognostic factors of chronic central serous chorioretinopathy after half-dose photodynamic therapy: A 3-year follow-up study. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0181479"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.ophtha.2014.09.034","article-title":"One-Year Outcomes with Half-Dose Verteporfin Photodynamic Therapy for Chronic Central Serous Chorioretinopathy","volume":"122","author":"Fujita","year":"2015","journal-title":"Ophthalmology"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ajo.2016.07.026","article-title":"A Multicenter Study on the Long-term Outcomes of Half-dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy","volume":"170","author":"Lai","year":"2016","journal-title":"Am. J. Ophthalmol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"101955","DOI":"10.1016\/j.pdpdt.2020.101955","article-title":"Comparison between the outcomes of fluorescein angiography-guided and indocyanine green angiography-guided half-time photodynamic therapy for central serous chorioretinopathy","volume":"31","author":"Hayashida","year":"2020","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ajo.2013.10.013","article-title":"Half-dose photodynamic therapy targeting the leakage point on the fluorescein angi-ography in acute central serous chorioretinopathy: A pilot study","volume":"157","author":"Kim","year":"2014","journal-title":"Am. J. Ophthalmol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/eye.2016.79","article-title":"The time of resolution and the rate of recurrence in acute central serous chorioretinopathy following spontaneous resolution and low-fluence photodynamic therapy: A case\u2013control study","volume":"30","author":"Ozkaya","year":"2016","journal-title":"Eye"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2147\/OPTH.S242926","article-title":"Risk of Recurrence and Transition to Chronic Disease in Acute Central Serous Chorioretinopathy","volume":"14","author":"Mohabati","year":"2020","journal-title":"Clin. Ophthalmol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ajo.2009.10.011","article-title":"Association between the efficacy of photodynamic therapy and indo-cyanine green angiography findings for central serous chorioretinopathy","volume":"149","author":"Inoue","year":"2010","journal-title":"Am. J. Ophthalmol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s00417-018-4003-z","article-title":"Clinical characteristics of chronic central serous chorioreti-nopathy patients with insufficient response to reduced-settings photodynamic therapy","volume":"256","author":"Dijkman","year":"2018","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.2147\/OPTH.S174573","article-title":"Clinical spectrum of severe chronic central serous chorioretinopathy and outcome of photodynamic therapy","volume":"12","author":"Mohabati","year":"2018","journal-title":"Clin. Ophthalmol."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Holz, F.G., Schmitz-Valckenberg, S., Spaide, R.F., and Bird, A.C. (2007). Atlas of Fundus Autofluorescence Imaging, Springer.","DOI":"10.1007\/978-3-540-71994-6"},{"key":"ref_51","first-page":"718","article-title":"In vivo fluorescence of the ocular fundus ex-hibits retinal pigment epithelium lipofuscin characteristics","volume":"36","author":"Delori","year":"1995","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1159\/000213743","article-title":"Accumulation of lipofuscin within retinal pigment epithelial cells results in enhanced sensitivity to photo-oxidation","volume":"41","author":"Brunk","year":"1995","journal-title":"Gerontology"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ajo.2013.02.016","article-title":"Near-infrared and short-wavelength autofluorescence in resolved central serous chorioretinopathy: Association with outer retinal layer abnormalities","volume":"156","author":"Kim","year":"2013","journal-title":"Am. J. Ophthalmol."},{"key":"ref_54","first-page":"1003","article-title":"Fundus autofluorescence in central serous chori-oretinopathy: Association with spectral-domain optical coherence tomography and fluorescein angiography","volume":"8","author":"Zhang","year":"2015","journal-title":"Int. J. Ophthalmol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/IAE.0b013e3182618bc5","article-title":"Foveal function and thickness after verteporfin photodynamic therapy in central serous chorioretinopathy with hyperautofluorescent subretinal deposits","volume":"33","author":"Pryds","year":"2013","journal-title":"Retina"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.ophtha.2005.01.003","article-title":"Fundus autofluorescence and central serous chorioretinopathy","volume":"112","author":"Spaide","year":"2005","journal-title":"Ophthalmology"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1038\/eye.2016.113","article-title":"Fundus autofluorescence imaging patterns in central serous chorioretinopathy according to chronicity","volume":"30","author":"Lee","year":"2016","journal-title":"Eye"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1600-0420.2005.00442.x","article-title":"Fundus autofluorescence in acute and chronic-recurrent central serous chorioretinopathy","volume":"83","author":"Framme","year":"2005","journal-title":"Acta Ophthalmol. Scand."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1444-0938.2011.00598.x","article-title":"Fundus autofluorescence in acute and chronic central se-rous chorioretinopathy","volume":"94","author":"Dinc","year":"2011","journal-title":"Clin. Exp. Optom."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1136\/bjo.2008.141564","article-title":"Near-infrared and short-wavelength autofluo-rescence imaging in central serous chorioretinopathy","volume":"93","author":"Ayata","year":"2009","journal-title":"Br. J. Ophthalmol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.ajo.2010.09.031","article-title":"Fundus Autofluorescence of Elongated Photoreceptor Outer Segments in Central Serous Chorioretinopathy","volume":"151","author":"Matsumoto","year":"2011","journal-title":"Am. J. Ophthalmol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"e835","DOI":"10.1111\/aos.13742","article-title":"Evolution of fundus autofluorescence patterns over time in patients with chronic central serous chorioretinopathy","volume":"96","author":"Zola","year":"2018","journal-title":"Acta Ophthalmol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1097\/IAE.0000000000002580","article-title":"Fundus autofluorescence patterns in central serous chorioretinopathy","volume":"40","author":"Han","year":"2020","journal-title":"Retina"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1126\/science.1957169","article-title":"Optical coherence tomography","volume":"254","author":"Huang","year":"1991","journal-title":"Science"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.ajo.2004.04.049","article-title":"Ophthalmic imaging by spectral optical coherence tomography","volume":"138","author":"Wojtkowski","year":"2004","journal-title":"Am. J. Ophthalmol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ajo.2008.05.032","article-title":"Enhanced Depth Imaging Spectral-Domain Optical Coherence Tomography","volume":"146","author":"Spaide","year":"2008","journal-title":"Am. J. Ophthalmol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.ajo.2014.02.034","article-title":"Choroidal Analysis in Healthy Eyes Using Swept-Source Optical Coherence Tomography Compared to Spectral Domain Optical Coherence Tomography","volume":"157","author":"Adhi","year":"2014","journal-title":"Am. J. Ophthalmol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"14354","DOI":"10.1073\/pnas.1307315110","article-title":"Optical imaging of the chorioretinal vasculature in the living human eye","volume":"110","author":"Kim","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Choi, W., Mohler, K.J., Potsaid, B., Lu, C.D., Liu, J.J., Jayaraman, V., Cable, A.E., Duker, J.S., Huber, R., and Fujimoto, J.G. (2013). Choriocapillaris and choroidal microvasculature imaging with ultrahigh speed OCT angiography. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0081499"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ophtha.2013.09.002","article-title":"Phase-variance optical coherence tomography: A technique for noninvasive angiography","volume":"121","author":"Schwartz","year":"2014","journal-title":"Ophthalmology"},{"key":"ref_71","first-page":"1254","article-title":"Teleophthalmology image-based navigated retinal laser therapy for diabetic macular edema: A concept of retinal telephotocoagulation","volume":"83","author":"Kozak","year":"2017","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.2147\/OPTH.S38363","article-title":"Correlation of spectral domain optical coherence tomography findings in acute central serous chorioretinopathy with visual acuity","volume":"6","author":"Ganekal","year":"2012","journal-title":"Clin. Ophthalmol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1136\/bjophthalmol-2017-311338","article-title":"Topographic-guided identification of leakage point in central serous cho-rioretinopathy: A base for fluorescein-angiography free focal laser photocoagulation","volume":"102","author":"Maltsev","year":"2018","journal-title":"Br. J. Ophthalmol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.3928\/23258160-20190401-16","article-title":"Clinical Application of Fluorescein Angiography-Free Navigated Focal Laser Photocoagulation in Central Serous Chorioretinopathy","volume":"50","author":"Maltsev","year":"2019","journal-title":"Ophthalmic Surg. Lasers Imaging Retin."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/IAE.0000000000001192","article-title":"\u201cVacuole\u201d sign adjacent to retinal pigment epithelial defects on spectral domain optical coherence tomography in central serous chorioretinopathy associated with subretinal fibrin","volume":"37","author":"Rajesh","year":"2017","journal-title":"Retina"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/IAE.0b013e31826710a0","article-title":"Early changes in foveal thickness in eyes with central serous chorioretinopathy","volume":"33","author":"Hata","year":"2013","journal-title":"Retina"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1034\/j.1600-0420.1999.770408.x","article-title":"Detection of shallow detachments in central serous chorioretinopathy","volume":"77","author":"Wang","year":"1999","journal-title":"Acta Ophthalmol. Scand."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0002-9394(02)01438-1","article-title":"Retinal atrophy in idiopathic central serous chorioretinopathy11InternetAdvance publication at ajo.com Feb 28, 2002","volume":"133","author":"Wang","year":"2002","journal-title":"Am. J. Ophthalmol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1600-0420.2005.00582.x","article-title":"Clinical characteristics of subretinal deposits in central serous chorioretinopathy","volume":"83","author":"Wang","year":"2005","journal-title":"Acta Ophthalmol. Scand."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1007\/s00417-014-2899-5","article-title":"Acute central serous chorioreti-nopathy: A correlation study between fundus autofluorescence and spectral-domain OCT","volume":"153","author":"Iacono","year":"2015","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/eye.2011.282","article-title":"Subthreshold diode laser micropulse photocoagulation versus intravitreal injections of bevacizumab in the treatment of central serous chorioretinopathy","volume":"26","author":"Koss","year":"2011","journal-title":"Eye"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"837","DOI":"10.3928\/23258160-20150909-08","article-title":"Randomized clinical trial to compare micro-pulse photocoagulation versus half-dose verteporfin photodynamic therapy in the treatment of central serous chorioretinopathy","volume":"46","author":"Kretz","year":"2015","journal-title":"Ophthalmic Surg. Lasers Imaging Retina"},{"key":"ref_83","first-page":"103","article-title":"Selective retina therapy with automatic real-time feedback-controlled dosimetry for chronic central serous chorioretinopathy in Korean patients","volume":"58","author":"Park","year":"2017","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/eye.2017.293","article-title":"Visual outcomes and anatomic changes after sub-threshold micropulse yellow laser (577-nm) treatment for chronic central serous chorioretinopathy: Long-term follow-up","volume":"32","author":"Arsan","year":"2018","journal-title":"Eye"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/eye.2016.142","article-title":"Comparison of subthreshold micropulse laser (577 nm) treatment and half-dose photodynamic therapy in patients with chronic central serous chorioretinopathy","volume":"30","author":"Scholz","year":"2016","journal-title":"Eye"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1007\/s12325-017-0559-y","article-title":"A Review of Subthreshold Micropulse Laser for Treatment of Macular Disorders","volume":"34","author":"Scholz","year":"2017","journal-title":"Adv. Ther."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/j.ophtha.2010.01.023","article-title":"Subfoveal Choroidal Thickness after Treatment of Central Serous Chorioretinopathy","volume":"117","author":"Maruko","year":"2010","journal-title":"Ophthalmology"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/ICB.0000000000000498","article-title":"Short-term findings on optical coherence tomography and microperimetry in chronic central serous chorioretinopathy patients treated with half-dose photodynamic therapy","volume":"12","author":"Dijkman","year":"2018","journal-title":"Retin Cases Brief Rep."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1097\/IAE.0b013e31822bf6b1","article-title":"One-year choroidal thickness results after photodynamic therapy for central serous chorioretinopathy","volume":"31","author":"Maruko","year":"2011","journal-title":"Retina"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1097\/IAE.0b013e31816b4b86","article-title":"Posterior cystoid retinal degeneration in central serous chorioretinopathy","volume":"28","author":"Manea","year":"2008","journal-title":"Retina"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000484100","article-title":"Angiographic and tomographic prognostic factors of chronic central serous chorioretinopathy treated with half-dose photodynamic therapy","volume":"240","author":"Chung","year":"2018","journal-title":"Ophthalmologica"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ajo.2011.08.015","article-title":"Association between the efficacy of half-dose photodynamic therapy with indocyanine green angiography and optical coherence tomography findings in the treatment of central serous chorioretinopathy","volume":"153","author":"Nicolo","year":"2012","journal-title":"Am. J. Ophthalmol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"9040","DOI":"10.1038\/s41598-019-45080-8","article-title":"Optical Coherence Tomography Angiography for Diagnosis of Choroidal Neovascularization in Chronic Central Serous Chorioretinopathy after Photodynamic Therapy","volume":"9","author":"Wu","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1007\/s00417-014-2780-6","article-title":"Spironolactone in the treatment of central serous chori-oretinopathy\u2014A case series","volume":"252","author":"Herold","year":"2014","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1097\/IAE.0000000000000614","article-title":"Spironolactone for nonresolving central serous chorioretinopathy: A random-ized controlled crossover study","volume":"35","author":"Bousquet","year":"2015","journal-title":"Retina"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.2147\/OPTH.S86778","article-title":"Oral mineralo-corticoid antagonists for recalcitrant central serous chorioretinopathy","volume":"9","author":"Chin","year":"2015","journal-title":"Clin. Ophthalmol."},{"key":"ref_97","first-page":"1444","article-title":"Clinical research of fenofibrate and spironolactone for acute central serous chorioretinopathy","volume":"9","author":"Chai","year":"2016","journal-title":"Int. J. Ophthalmol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1167\/tvst.5.2.2","article-title":"Oral mineralocorti-coid-receptor antagonists: Real-life experience in clinical subtypes of nonresolving central serous chorioretinopathy with chronic epitheliopathy","volume":"5","author":"Daruich","year":"2016","journal-title":"Transl. Vis. Sci. Technol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000444058","article-title":"Mineralocorticoid Antagonists in the Treatment of Central Serous Chorioretinopathy: A Comparative Analysis","volume":"56","author":"Kapoor","year":"2016","journal-title":"Ophthalmic Res."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"281","DOI":"10.4103\/jovr.jovr_139_16","article-title":"Visual and anatomical outcomes of spironolactone therapy in patients with chronic central serous chorioretinopathy","volume":"12","author":"Aghdam","year":"2017","journal-title":"J. Ophthalmic Vis. Res."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00417-016-3436-5","article-title":"Long-term results and recurrence rates after spironolac-tone treatment in non-resolving central serous chorio-retinopathy (cscr)","volume":"255","author":"Herold","year":"2017","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s10792-016-0377-2","article-title":"Central Serous Chorioretinopathy Study Group. Comparison of two mineralcorticosteroids receptor antagonists for the treatment of central serous chorioretinopathy","volume":"37","author":"Pichi","year":"2017","journal-title":"Int. Ophthalmol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/eye.2017.295","article-title":"Response of central serous chorioretinopathy evaluated by multimodal retinal imaging","volume":"32","author":"Sacconi","year":"2018","journal-title":"Eye"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ajo.2018.09.034","article-title":"Predictive Factors of Response to Mineralocorticoid Receptor Antagonists in Nonresolving Central Serous Chorioretinopathy","volume":"198","author":"Bousquet","year":"2019","journal-title":"Am. J. Ophthalmol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1007\/s00417-016-3373-3","article-title":"Clinical experi-ence with eplerenone to treat chronic central serous chorioretinopathy","volume":"254","author":"Cakir","year":"2016","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Borrelli, E., Zuccaro, B., Zucchiatti, I., Parravano, M., Querques, L., Costanzo, E., Sacconi, R., Prascina, F., Scarinci, F., and Bandello, F. (2019). Optical coherence tomography parameters as predictors of treatment response to ep-lerenone in central serous chorioretinopathy. J. Clin. Med., 8.","DOI":"10.3390\/jcm8091271"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41433-018-0212-2","article-title":"Clinical efficay of eplerenone versus placebo for central serous chorioretinopathy: Study pro-tocol for the VICI randomised controlled trial","volume":"33","author":"Willcox","year":"2019","journal-title":"Eye"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0140-6736(19)32981-2","article-title":"Eplerenone for chronic central serous cho-rioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): A randomised, double-blind, placebo-controlled trial","volume":"395","author":"Lotery","year":"2020","journal-title":"Lancet"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"4659","DOI":"10.1167\/iovs.12-10991","article-title":"Optical Coherence Tomography\u2013Assisted Enhanced Depth Imaging of Central Serous Chorioretinopathy","volume":"54","author":"Yang","year":"2013","journal-title":"Investig. Opthalmol. Vis. Sci."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/IAE.0000000000000742","article-title":"En face imaging of pachychoroid spectrum disorders with swept-source optical coherence tomography","volume":"36","author":"Dansingani","year":"2016","journal-title":"Retina"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1159\/000448342","article-title":"Investigation of the Etiology of Central Serous Chorioretinopathy Using En-Face Optical Coherence Tomography and Indocyanine Green Angiography","volume":"236","author":"Shinojima","year":"2016","journal-title":"Ophthalmologica"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1136\/bjophthalmol-2016-308428","article-title":"En face choroidal vascular feature imaging in acute and chronic central se-rous chorioretinopathy using swept source optical coherence tomography","volume":"101","author":"Lee","year":"2017","journal-title":"Br. J. Ophthalmol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1097\/IAE.0b013e3182953df4","article-title":"Pachychoroid pigment epitheliopathy","volume":"33","author":"Warrow","year":"2013","journal-title":"Retina"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/IAE.0000000000000331","article-title":"Pachychoroid neovasculopathy","volume":"35","author":"Pang","year":"2015","journal-title":"Retina"},{"key":"ref_115","first-page":"3718","article-title":"Risk factors and choroidal changes in patients with unilateral versus bilateral chronic active CSCR","volume":"56","author":"Dirani","year":"2015","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.4103\/ijo.IJO_2030_18","article-title":"Evaluation of choroidal hyperreflective dots in acute and chronic central serous chorioretinopathy","volume":"67","author":"Hanumunthadu","year":"2019","journal-title":"Indian J. Ophthalmol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1097\/IAE.0000000000000929","article-title":"Baseline spectral domain optical coherence tomographic hyperreflective foci as a predictor of visual outcome and recurrence for central serous chorioretinopathy","volume":"36","author":"Lee","year":"2016","journal-title":"Retina"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ajo.2012.02.031","article-title":"Time-periodic characteristics in the morphology of idiopathic central serous chorioretinopathy evaluated by volume scan using spectral-domain optical coherence tomography","volume":"154","author":"Song","year":"2012","journal-title":"Am. J. Ophthalmol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.2147\/OPTH.S160956","article-title":"Clinical characteristics and long-term visual outcome of severe phenotypes of chronic central serous chorioretinopathy","volume":"12","author":"Mohabati","year":"2018","journal-title":"Clin. Ophthalmol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00006982-200202000-00005","article-title":"A Long-term follow-up study of severe variant of central serous chorioretinopathy","volume":"22","author":"Otsuka","year":"2002","journal-title":"Retina"},{"key":"ref_121","first-page":"379","article-title":"Long-term follow-up of central serous retinopathy in 150 patients","volume":"81","author":"Coutinho","year":"1992","journal-title":"Doc. Ophthalmol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00006982-200302000-00001","article-title":"Cystoid macular degeneration in chronic central serous chorioretinopathy","volume":"23","author":"Iida","year":"2003","journal-title":"Retina"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.ophtha.2017.12.002","article-title":"Efficacy and safety of ranibizumab 0.5 mg for the treatment of macular edema resulting from uncommon causes: Twelve-month findings from prometheus","volume":"125","author":"Staurenghi","year":"2018","journal-title":"Ophthalmology"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1097\/IAE.0b013e318175421f","article-title":"Risk factors for posterior cystoid retinal de-generation in central serous chorioretinopathy","volume":"28","author":"Piccolino","year":"2008","journal-title":"Retina"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1097\/IAE.0000000000002683","article-title":"Clinical characteristics and outcome of posterior cystoid macular degeneration in chronic central serous chorioretinopathy","volume":"40","author":"Mohabati","year":"2019","journal-title":"Retina"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1136\/bjophthalmol-2018-313048","article-title":"Optical coherence to-mography angiography findings in cystoid macular degeneration associated with central serous chorioretinopathy","volume":"103","author":"Sahoo","year":"2019","journal-title":"Br. J. Ophthalmol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.preteyeres.2015.05.003","article-title":"Central serous chori-oretinopathy: Recent findings and new physiopathology hypothesis","volume":"48","author":"Daruich","year":"2015","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1755-3768.2008.01468.x","article-title":"Alterations of intraretinal layers in acute central serous chorioretinopathy","volume":"87","author":"Ahlers","year":"2009","journal-title":"Acta Ophthalmol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1442-9071.2006.01447.x","article-title":"Alterations of retinal pigment epithelium in central serous chorioretinopathy","volume":"35","author":"Hirami","year":"2007","journal-title":"Clin. Exp. Ophthalmol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.4103\/ijo.IJO_377_18","article-title":"\u201cDouble-layer sign\u201d on spectral domain optical coherence tomography in pachychoroid spectrum disease","volume":"66","author":"Sheth","year":"2018","journal-title":"Indian J. Ophthalmol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.ajo.2015.02.002","article-title":"Flat irregular retinal pigment epithelium de-tachments in chronic central serous chorioretinopathy and choroidal neovascularization","volume":"159","author":"Hage","year":"2015","journal-title":"Am. J. Ophthalmol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.ajo.2015.08.028","article-title":"Optical coherence tomography angi-ography of shallow irregular pigment epithelial detachments in pachychoroid spectrum disease","volume":"160","author":"Dansingani","year":"2015","journal-title":"Am. J. Ophthalmol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/01.iae.0000249386.63482.05","article-title":"Tomographic features of branching vascular networks in polypoidal vhoroidal vasculopathy","volume":"27","author":"Sato","year":"2007","journal-title":"Retina"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/IAE.0000000000001580","article-title":"Optical coherence tomography angiography of flat irregular pigment epithelium detachment in chronic central serous chorioretinopathy","volume":"38","author":"Bousquet","year":"2018","journal-title":"Retina"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.ajo.2015.06.016","article-title":"Chronic central serous chorioretinopathy imaged by optical coherence tomographic angiography","volume":"160","author":"Eandi","year":"2015","journal-title":"Am. J. Ophthalmol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1001\/jamaophthalmol.2015.1320","article-title":"Association of choroidal neovascularization and central serous chorioretinopathy with optical coherence tomography angiography","volume":"133","author":"Ferrara","year":"2015","journal-title":"JAMA Ophthalmol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3928\/23258160-20160126-05","article-title":"Vascularization of irregular retinal pigment epithelial detach-ments in chronic central serous chorioretinopathy evaluated with OCT angiography","volume":"47","author":"Rosenblatt","year":"2016","journal-title":"Ophthalmic Surg. Lasers Imaging Retina"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.ajo.2014.06.015","article-title":"Study of subretinal exudation and consequent changes in acute central serous chorioreti-nopathy by optical coherence tomography","volume":"158","author":"Yu","year":"2014","journal-title":"Am. J. Ophthalmol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.ophtha.2016.03.017","article-title":"Bullous variant of central serous chorioretinopathy: Expansion of phenotypic features using multimodal imaging","volume":"123","author":"Balaratnasingam","year":"2016","journal-title":"Ophthalomolgy"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/s41433-020-0858-4","article-title":"Comparison of the outcomes of photodynamic therapy for central serous chorioretinopathy with or without subfoveal fibrin","volume":"35","author":"Liang","year":"2020","journal-title":"Eye"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1016\/S0161-6420(96)30386-2","article-title":"Central Serous Chorioretinopathy in Younger and Older Adults","volume":"103","author":"Spaide","year":"1996","journal-title":"Ophthalmology"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00006982-200202000-00004","article-title":"Factors associated with reduced visual acuity during longterm follow-up of patients with idiopathic central serous chorioretinopathy","volume":"22","author":"Loo","year":"2002","journal-title":"Retina"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1097\/IAE.0b013e3182680a66","article-title":"Type 1 (sub-retinal pigment epithelial) neovascularization in central serous chorioretinopathy masquerading as neovascular age-related macular degeneration","volume":"32","author":"Fung","year":"2012","journal-title":"Retina"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1080\/08820538.2018.1503690","article-title":"Central Serous Chorioretinopathy: Clinical Characteristics Associated with Visual Outcomes","volume":"33","author":"Nicholson","year":"2018","journal-title":"Semin. Ophthalmol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"7217906","DOI":"10.1155\/2020\/7217906","article-title":"Choroidal neovascularization secondary to central serous chori-oretinopathy: OCT angiography findings and risk factors","volume":"2020","author":"Yeo","year":"2020","journal-title":"J. Ophthalmol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1038\/s41598-019-40406-y","article-title":"Risk factors and outcomes of choroidal neovascularization secondary to central serous chorioretinopathy","volume":"9","author":"Lee","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"100770","DOI":"10.1016\/j.preteyeres.2019.07.003","article-title":"Central serous chorioretinopathy: Towards an evi-dence-based treatment guideline","volume":"73","author":"Yzerb","year":"2019","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.ajo.2014.08.025","article-title":"Sensitivity and specificity of spectral-domain optical coherence tomography in detecting idiopathic polypoidal choroidal vasculopathy","volume":"158","author":"Keane","year":"2014","journal-title":"Am. J. Ophthalmol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1097\/IAE.0000000000000655","article-title":"Outcomes of treatment of choroidal neovasculari-zation associated with central serous chorioretinopathy with intravitreal antiangiogenic agents","volume":"35","author":"Chhablani","year":"2015","journal-title":"Retina"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1097\/IAE.0000000000000804","article-title":"Antiangiogenics in choroidal neovascularization associated with laser in central serous chorioretinopathy","volume":"36","author":"Chhablani","year":"2016","journal-title":"Retina"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1097\/IAE.0000000000001744","article-title":"Efficacy and safety of ranibizumab for the treatment of choroidal neovascularization due to uncommon cause: Twelve-month results of the minerva study","volume":"38","author":"Lai","year":"2018","journal-title":"Retina"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1097\/IAE.0000000000001750","article-title":"Anti-vascular endothelial growth factor therapy versus photodynamic therapy in the treatment of choroidal neovascularization secondary to central serous chorioretinopathy","volume":"38","author":"Peiretti","year":"2018","journal-title":"Retina"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1001\/jamaophthalmol.2017.4030","article-title":"Efficacy and safety of ranibizumab with or without verteporfin photodynamic therapy for polypoidal cho-roidal vasculopathy: A randomized clinical trial","volume":"135","author":"Koh","year":"2017","journal-title":"JAMA Ophthalmol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1001\/jamaophthalmol.2018.1804","article-title":"Efficacy and safety of intravitreal aflibercept for polypoidal choroidal vasculopathy in the planet study: A randomized clinical trial","volume":"136","author":"Lee","year":"2018","journal-title":"JAMA Ophthalmol."}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/14\/2\/105\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:17:15Z","timestamp":1760159835000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/14\/2\/105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,29]]},"references-count":154,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,2]]}},"alternative-id":["ph14020105"],"URL":"https:\/\/doi.org\/10.3390\/ph14020105","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,29]]}}}